Article Details
Retrieved on: 2021-06-24 11:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company included PF-remdesivir, an FDA-approved RNA polymerase inhibitor, and another SARS-CoV-2 3CL protease inhibitor – PF-00835231, in ...
Article found on: biopharmajournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here